摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)acetonitrile

中文名称
——
中文别名
——
英文名称
(6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)acetonitrile
英文别名
(+/-)-cis-2,2-Dimethyl-6-(2-propenyl)-1,3-dioxane-4-acetonitrile;2-[(4S,6R)-2,2-dimethyl-6-prop-2-enyl-1,3-dioxan-4-yl]acetonitrile
(6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)acetonitrile化学式
CAS
——
化学式
C11H17NO2
mdl
——
分子量
195.261
InChiKey
KOXRGLSAKBHDON-ZJUUUORDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    42.2
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)acetonitrile间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 以86%的产率得到(2,2-dimethyl-6-oxiranylmethyl-1,3-dioxan-4-yl)acetonitrile
    参考文献:
    名称:
    改进的1,1-二甲基乙基6-氰基甲基-2,2-二甲基-1,3-二恶烷-4-乙酸酯的合成,这是阿托伐他汀合成的关键中间体
    摘要:
    描述了一种改进的1,1-二甲基乙基6-氰基甲基-2,2-二甲基-1,3-二恶烷-4-乙酸酯的合成,其是合成有效的HMG-CoA还原酶抑制剂阿托伐他汀的关键中间体。该合成基于庚七,1,6-二烯-4-醇到4-烯丙基-6-碘甲基-1,3-二恶烷-2-酮的碘内酯化,该过程可分几步转化为(6-烯丙基- 2,2-二甲基-1,3-二恶烷-4-基)-乙腈。该中间体通过相应的醛或通过(2,2-二甲基-6-环氧乙烷基甲基-1,3-二恶烷- 4-基)乙腈。
    DOI:
    10.1016/s0040-4039(02)00175-2
  • 作为产物:
    描述:
    参考文献:
    名称:
    改进的1,1-二甲基乙基6-氰基甲基-2,2-二甲基-1,3-二恶烷-4-乙酸酯的合成,这是阿托伐他汀合成的关键中间体
    摘要:
    描述了一种改进的1,1-二甲基乙基6-氰基甲基-2,2-二甲基-1,3-二恶烷-4-乙酸酯的合成,其是合成有效的HMG-CoA还原酶抑制剂阿托伐他汀的关键中间体。该合成基于庚七,1,6-二烯-4-醇到4-烯丙基-6-碘甲基-1,3-二恶烷-2-酮的碘内酯化,该过程可分几步转化为(6-烯丙基- 2,2-二甲基-1,3-二恶烷-4-基)-乙腈。该中间体通过相应的醛或通过(2,2-二甲基-6-环氧乙烷基甲基-1,3-二恶烷- 4-基)乙腈。
    DOI:
    10.1016/s0040-4039(02)00175-2
点击查看最新优质反应信息

文献信息

  • Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one
    申请人:Warner-Lambert Company
    公开号:US05149837A1
    公开(公告)日:1992-09-22
    An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluoro-phenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetr ahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.
    本文介绍了一种改进的方法,通过新的合成方法将1,6-庚二烯-4-醇转化为所需产物,制备了转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮,共进行了八个步骤。此外,还介绍了一种改进的方法,通过新的合成方法将4-甲基-3-氧代-N-苯基戊酰胺转化为所需产物,或者通过一步将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N,β-二苯基苯丁酰胺转化为所需产物,制备了(2R-转)和转-(.+-.)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺。此外,还介绍了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺的方法,以及用于该过程的其他有价值的中间体。
  • Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one
    申请人:Warner-Lambert Co.
    公开号:US05216174A1
    公开(公告)日:1993-06-01
    An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetra hydro4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3carboxamide by a novel synthesis where 4-methyl-3-oxoN-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenzen ebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1Hpyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.
    本文描述了一种改进的方法,通过新型合成将1,6-庚二烯-4-醇转化为所需产物,制备了转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮,共进行了八个操作。此外,还描述了一种改进的方法,通过新型合成将4-甲基-3-氧代N-苯基戊酰胺转化为所需产物,或者通过一步将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N,β-二苯基苯丁烷酰胺转化为所需产物,制备了(2R-转型)和转型-(±)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺。此外,还提供了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转型)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡咯-2-基)乙基]-1H-吡咯-3-羧酰胺的方法,以及用于制备这些化合物的其他有价值的中间体。
  • Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one
    申请人:Warner-Lambert Company
    公开号:US05003080A1
    公开(公告)日:1991-03-26
    An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N-4-diphenyl-1-[2-tetrah ydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.
    本发明描述了一种改进的方法,通过新的合成方法将1,6-庚二烯-4-醇转化为所需产物,制备转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮,共进行了八次操作。此外,本发明还描述了一种改进的方法,通过新的合成方法将4-甲基-3-氧代-N-苯基戊酰胺在八次操作中转化为所需产物,或者通过一步将4-氟-.alpha.-[2-甲基-1-氧代丙基]-.gamma.-氧代-N,.beta.-二苯基苯丁酰胺转化为所需产物,制备(2R-转)和转-(.+-.)-5-(4-氟苯基)-2-(1-甲基乙基)-N-4-二苯基-1-[2-四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺。此外,本发明还描述了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺的方法,以及用于该过程中使用的其他有价值的中间体。
  • Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one
    申请人:Warner-Lambert Company
    公开号:US05124482A1
    公开(公告)日:1992-06-23
    An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrah ydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenze nebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahy dro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.
    本发明描述了一种改进的方法,通过一种新的合成方法,将1,6-庚二烯-4-醇转化为所需的产物,从而制备出改良的转-6-[2-(取代吡咯-1-基)烷基]吡喃-2-酮。此外,本发明还描述了一种改进的方法,通过一种新的合成方法,将4-甲基-3-氧代-N-苯基戊酰胺在八个步骤中转化为所需的产物,或者将4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N,β-二苯基苯基丁酰胺在一步中转化为所需的产物,用于制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺,以及用于该过程中使用的其他有价值的中间体。此外,本发明还描述了一种从(R)-4-氰基-3-[[(1,1-二甲基乙基)二甲基硅氧基]丁酸制备(2R-转)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1-[2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基]-1H-吡咯-3-羧酰胺的方法。
  • Improved process for trans-6-[2-(substituted-pyrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0330172B1
    公开(公告)日:1994-08-10
查看更多